Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan

Published:2006 Issue:3 Volume:29 Page:261-272
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Safety

Author:

Huang Weng-Foung,Hsiao Fei-Yuan,Tsai Yi-Wen,Wen Yu-Wen,Shih Yaw-Tang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference17 articles.

1. The Coxibs, Selective Inhibitors of Cyclooxygenase-2

2. Cyclooxygenase-2 Inhibitors

3. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery

4. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

5. Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Celecoxib decreases mitochondrial complex IV activity and induces oxidative stress in isolated rat heart mitochondria: An analysis for its cardiotoxic adverse effect;Journal of Biochemical and Molecular Toxicology;2021-10-19

2. Cardiac electrophysiological effects of ibuprofen in dog and rabbit ventricular preparations: possible implication to enhanced proarrhythmic risk;Canadian Journal of Physiology and Pharmacology;2021-01

3. Electrochemical oxidation of anti-inflammatory drug meloxicam and its determination using boron doped diamond electrode;Journal of Electroanalytical Chemistry;2020-02

4. Meloxicam and risk of myocardial infarction: a population-based nested case–control study;Rheumatology International;2017-10-13

5. Celecoxib for the treatment of atherosclerosis;Expert Opinion on Investigational Drugs;2016-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3